LCTX holders · CITADEL ADVISORS LLC 13F · LCTX stock
CITADEL ADVISORS LLC Lineage Cell Therapeutics Inc (LCTX) 13F holding
CITADEL ADVISORS LLC reported 130,948 LCTX shares valued at $206.9K as of 2026-03-31. Share lines from that 13F summed, options excluded; value is the 13F-reported market value in US dollars, as reported on Form 13F, not a live feed.
This is the newest LCTX 13F on file for this filer CIK, and it is older than the quarter ended 2026-06-30. It is kept for history and left out of the LCTX holders table.
| Report | Shares | Value | Class |
|---|---|---|---|
| 2026-03-31 | 130,948 | $206.9K | COM |
| 2025-12-31 | 507,052 | $846.8K | COM |
| 2025-09-30 | 193,968 | $327.8K | COM |
| 2025-06-30 | 185,481 | $168.3K | COM |
Not investment advice. Holdings as reported on Form 13F; EDGAR is the official record.